
Adult Immunization
Latest News

FDA Accepts Axsome NDA for AXS-12 for Cataplexy in Narcolepsy

Subcutaneous Lecanemab Shows Comparable Exposure in Early Alzheimer Disease

WHO Warns Global Cancer Cases Could Reach 35 Million Annually by 2050

AI Drafts for Patient Portal Replies May Increase Primary Care Clinician Editing Burden

Tralokinumab Phase 2 TRAPEDS-1 Trial Shows Consistent PK, Safety in Children With Atopic Dermatitis

Shorts










Latest Videos
All News

FDA approval makes Differin Epiduo Acne Gel available OTC for patients aged 12 years or older with acne.

Clinicians discuss DKA risk, sick day plans, CGM use, and ketone testing in primary care.

Eden Miller, DO, and panelists discuss DKA recognition gaps, ketone testing barriers, and the future of dual glucose-ketone sensing.

The FDA recently approved the first generic baloxavir tablet for influenza treatment and postexposure prophylaxis in patients aged 5 years or older.

CGM prescribing in primary care was associated with lower HbA1c levels, fewer hospitalizations, and fewer ED visits among insulin-treated adults.

A primary care telehealth mindfulness program improved chronic low back pain and pain interference through 12 months in OPTIMUM.

FDA authorized a reduced-risk claim for 20 ZYN nicotine pouches for adults who switch completely from cigarettes.

A 10-week video-based cognitive rehabilitation program improved patient-set goals in adults with long COVID cognitive symptoms.

Recent FDA actions include updates on COVID-19 prophylaxis, ADHD, PTSD neuromodulation, and pediatric psoriasis and psoriatic arthritis care.

















































































































































































